Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $56.10 | Total: $280.50 |
| 1 | 10 | $47.52 | Total: $475.20 |
| 1 | 25 | $40.26 | Total: $1,006.50 |
| 1 | 50 | $34.32 | Total: $1,716.00 |
| 1 | 100 | $29.70 | Total: $2,970.00 |
Overview
BDA-366, a potent Bcl2 antagonist, selectively binds the Bcl2-BH4 domain with high affinity (Ki = 3.3 nM), inducing a conformational change that nullifies its antiapoptotic function, thereby transforming it into a pro-apoptotic entity. This compound effectively suppresses lung cancer cell growth[1].
Chemical Properties
| Molecular Formula | C24H29N3O4 |
| Molecular Weight | 423.5 |
| CAS Numbers | 1909226-00-1 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CCN(CC)C[C@H](CNc(c(C(c1c2cccc1)=O)c1C2=O)ccc1NC[C@@H]1OC1)O |
Storage and Handling
0C Short Term, -20C Long Term